UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1319P Interdependence of KRAS and TP53 mutations in predicting benefit from immune checkpoint inhibitor (ICI) in non-squamous NSCLC

Annals of oncology, 2020-09, Vol.31, p.S852-S852

2020

Volltextzugriff (PDF)

133PA nomogram for predicting the malignant diagnosis of BI-RADS US category 4A lesions in women with dense breast tissue

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Volltextzugriff (PDF)

1341P Real-world molecular testing, treatment patterns and clinical outcomes in Chinese advanced NSCLC patients, who have progressed on first-line EGFR-TKI therapy (PISCES)

Annals of oncology, 2023-10, Vol.34, p.S773-S773

2023

Volltextzugriff (PDF)

135P c-Ros oncogene 1 receptor tyrosine kinase (ROS1) partners identified by next-generation sequencing in Chinese patients with solid tumours

Annals of oncology, 2020-09, Vol.31, p.S293-S294

2020

Volltextzugriff (PDF)

137P Phase I dose-finding study of a novel anti-CTLA-4 antibody ADG116 as monotherapy in patients with advanced solid tumors

Annals of oncology, 2021-12, Vol.32, p.S1436-S1437

2021

Volltextzugriff (PDF)

139P Rearranged during transfection (RET) partners identified by next-generation sequencing in Chinese patients with solid tumours

Annals of oncology, 2020-09, Vol.31, p.S295-S295

2020

Volltextzugriff (PDF)

140-GHz V-Shaped Microstrip Meander-Line Traveling Wave Tube

Journal of electromagnetic waves and applications, 2012-01, Vol.26 (1), p.89-98

2012

Volltextzugriff (PDF)

1403P A phase II study of tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: Long-term follow-up outcomes of TD-NICE

Annals of oncology, 2024-09, Vol.35, p.S879-S879

2024

Volltextzugriff (PDF)

1433P A phase I/II study of FG-M108 plus capecitabine and oxaliplatin (CAPOX) as first-line (1L) treatment for patients with CLDN18.2+/HER2- advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma

Annals of oncology, 2024-09, Vol.35, p.S892-S892

2024

Volltextzugriff (PDF)

1439P Brain radiotherapy combined with camrelizumab and platinum-based chemotherapy as first-line treatment for advanced NSCLC with brain metastases: A multicenter, open-label, single-arm, phase II study

Annals of oncology, 2023-10, Vol.34, p.S818-S818

2023

Volltextzugriff (PDF)

1479O - Integrated genomic and DNA methylation analyses of non-small cell lung cancer patients with brain metastases

Annals of oncology, 2019-10, Vol.30, p.v602-v603

2019

Volltextzugriff (PDF)

1479OIntegrated genomic and DNA methylation analyses of non-small cell lung cancer patients with brain metastases

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

15 W output power diode-pumped solid-state lasers at 515 nm

Laser physics letters, 2007-01, Vol.4 (1), p.30-32

2007

Volltextzugriff (PDF)

150 Micron Spatial Resolution using Photon Counting Detector CT Technology: Technical Performance and First Patient Images

Investigative radiology, 2018-11, Vol.53 (11), p.655-662

2018

Volltextzugriff (PDF)

150-μm Spatial Resolution Using Photon-Counting Detector Computed Tomography Technology: Technical Performance and First Patient Images

Investigative radiology, 2018-11, Vol.53 (11), p.655-662

2018

Volltextzugriff (PDF)

1530P Preliminary result of a phase Ib study: Efficacy and safety of FG-M108 plus gemcitabine and nab-paclitaxel in patients with Claudin18.2 positive locally advanced unresectable or metastaticpancreatic cancer

Annals of oncology, 2024-09, Vol.35, p.S933-S933

2024

Volltextzugriff (PDF)

1540P Tislelizumab combined with neoadjuvant chemoradiotherapy for resectable locally advanced oesophageal squamous cell carcinoma: A prospective, phase II clinical study

Annals of oncology, 2023-10, Vol.34, p.S865-S865

2023

Volltextzugriff (PDF)

16.4 W laser output at 1.34 μm with twin Nd:YVO 4 crystals and double-end-pumping structure

Laser physics letters, 2008-01, Vol.5 (1), p.21-24

2008

Volltextzugriff (PDF)

16.4 W laser output at 1.34 µm with twin Nd:YVO4 crystals and double-end-pumping structure

Laser physics letters, 2008-01, Vol.5 (1), p.21-24

2008

Volltextzugriff (PDF)

164PPD-L1 expression affect the efficacy of pemetrexed maintenance therapy in real-world patients with advanced non-squamous NSCLC

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

194MO Phase II study of low-dose radiation (LDRT) plus durvalumab (D) and etoposide/platinum (EP) as first-line treatment in ES-SCLC (LEAD): Efficacy and safety results

ESMO open, 2024-03, Vol.9, p.102767, Article 102767

2024

Volltextzugriff (PDF)

197P Combining stereotactic body radiation and low-dose radiation (EclipseRT) with PD-1 inhibitor in mice models and patients with bulky tumor

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S147-S148

2023

Volltextzugriff (PDF)

1987P Discordant genomic correlates of PD-L1 expression in lung adenocarcinoma among multiple cohorts using dissimilar PD-L1 testing techniques

Annals of oncology, 2020-09, Vol.31, p.S1113-S1113

2020

Volltextzugriff (PDF)

2.0 W diode-pumped Er : Yb : Y Al 3 ( B O 3 ) 4 laser at 1.5 - 1.6 μ m

Applied physics letters, 2006-12, Vol.89 (24), p.241111-241111-3

2006

Volltextzugriff (PDF)

2.0 W diode-pumped Er:Yb:YAl3(BO3)4 laser at 1.5–1.6μm

Applied physics letters, 2006-12, Vol.89 (24)

2006

Volltextzugriff (PDF)

26 – 50 von 9.564

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7.876)
Mit Volltextzugriff
(7.989)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(6.737)
Life Sciences & Biomedicine
(2.684)
Physical Sciences
(2.604)
Technology
(2.396)
Physics
(1.665)
Humans
(1.641)
Materials Science
(1.021)
Engineering
(981)
Animals
(973)
Exact Sciences And Technology
(904)
Male
(878)
Female
(873)
Biological And Medical Sciences
(722)
Chemistry
(674)
Materials Science, Multidisciplinary
(635)
Physics, Applied
(581)
Engineering, Electrical & Electronic
(523)
Middle Aged
(481)
Adult
(464)
Computer Science
(463)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(3.726)
EZB Electronic Journals Library
(3.337)
MEDLINE
(2.514)
Elsevier ScienceDirect Journals Complete
(2.050)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.435)
NUS Single-Journal Subscriptions
(1.398)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(1.359)
IngentaConnect Journals
(1.329)
IEL
(777)
Wiley Online Library Journals
(759)
SpringerLink_现刊
(683)
Wiley Online Library
(535)
American Physical Society Journals
(499)
PROLA - Physical Review Online Archive
(396)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(385)
Taylor & Francis Journals
(314)
AIP Journals
(296)
Nature_系列刊
(279)
Oxford journals
(204)
Taylor & Francis:Master (3349 titles)
(196)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

1319P Interdependence of KRAS and TP53 mutations in predicting benefit from immune checkpoint inhibitor (ICI) in non-squamous NSCLC

133PA nomogram for predicting the malignant diagnosis of BI-RADS US category 4A lesions in women with dense breast tissue

1341P Real-world molecular testing, treatment patterns and clinical outcomes in Chinese advanced NSCLC patients, who have progressed on first-line EGFR-TKI therapy (PISCES)

135P c-Ros oncogene 1 receptor tyrosine kinase (ROS1) partners identified by next-generation sequencing in Chinese patients with solid tumours

137P Phase I dose-finding study of a novel anti-CTLA-4 antibody ADG116 as monotherapy in patients with advanced solid tumors

139P Rearranged during transfection (RET) partners identified by next-generation sequencing in Chinese patients with solid tumours

140-GHz V-Shaped Microstrip Meander-Line Traveling Wave Tube

1403P A phase II study of tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: Long-term follow-up outcomes of TD-NICE

1433P A phase I/II study of FG-M108 plus capecitabine and oxaliplatin (CAPOX) as first-line (1L) treatment for patients with CLDN18.2+/HER2- advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma

1439P Brain radiotherapy combined with camrelizumab and platinum-based chemotherapy as first-line treatment for advanced NSCLC with brain metastases: A multicenter, open-label, single-arm, phase II study

1479O - Integrated genomic and DNA methylation analyses of non-small cell lung cancer patients with brain metastases

1479OIntegrated genomic and DNA methylation analyses of non-small cell lung cancer patients with brain metastases

15 W output power diode-pumped solid-state lasers at 515 nm

150 Micron Spatial Resolution using Photon Counting Detector CT Technology: Technical Performance and First Patient Images

150-μm Spatial Resolution Using Photon-Counting Detector Computed Tomography Technology: Technical Performance and First Patient Images

1530P Preliminary result of a phase Ib study: Efficacy and safety of FG-M108 plus gemcitabine and nab-paclitaxel in patients with Claudin18.2 positive locally advanced unresectable or metastaticpancreatic cancer

1540P Tislelizumab combined with neoadjuvant chemoradiotherapy for resectable locally advanced oesophageal squamous cell carcinoma: A prospective, phase II clinical study

16.4 W laser output at 1.34 μm with twin Nd:YVO 4 crystals and double-end-pumping structure

16.4 W laser output at 1.34 µm with twin Nd:YVO4 crystals and double-end-pumping structure

164PPD-L1 expression affect the efficacy of pemetrexed maintenance therapy in real-world patients with advanced non-squamous NSCLC

194MO Phase II study of low-dose radiation (LDRT) plus durvalumab (D) and etoposide/platinum (EP) as first-line treatment in ES-SCLC (LEAD): Efficacy and safety results

197P Combining stereotactic body radiation and low-dose radiation (EclipseRT) with PD-1 inhibitor in mice models and patients with bulky tumor

1987P Discordant genomic correlates of PD-L1 expression in lung adenocarcinoma among multiple cohorts using dissimilar PD-L1 testing techniques

2.0 W diode-pumped Er : Yb : Y Al 3 ( B O 3 ) 4 laser at 1.5 - 1.6 μ m

2.0 W diode-pumped Er:Yb:YAl3(BO3)4 laser at 1.5–1.6μm

Suchergebnisse filtern